本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Therapeutics

20.26
+1.729.28%
盘后20.260.00000.00%17:28 EDT
成交量:21.52万
成交额:420.13万
市值:5.58亿
市盈率:-8.66
高:20.39
开:18.54
低:18.13
收:18.54
数据加载中...
2025/04/04

重要事件披露

Form 8-K - Current report
2025/03/19

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/19

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/19

重要事件披露

Form 8-K - Current report
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

重要事件披露

Form 8-K - Current report
2024/10/28

重要事件披露

Form 8-K - Current report
2024/09/17

SEC问询函

Form CORRESP - Correspondence
2024/09/12

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/14

重要事件披露

Form 8-K - Current report
2024/08/12

重要事件披露

Form 8-K - Current report
2024/07/29

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/07/15

重要事件披露

Form 8-K - Current report
2024/05/21

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/08

重要事件披露

Form 8-K - Current report
2024/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/09

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]